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Abstract  
Overweight and obesity (OW and OB) have been on the increase globally and posed health risks 
to the world’s population of all ages, including pre-born babies, children, adolescents, adults and 
elderly people, via their comorbid conditions. Excellent examples of comorbidities associated 
with obesity include cancer, cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM). 
In this article, we aimed to review and update scientific evidence regarding the relationships 
between obesity and its common physical health consequences, including CVD, T2DM, 
hypertension, ischemic stroke, cancer, dyslipidemia and reproductive disorders. In addition, the 
economic burden of OW and OB will be discussed. Abundant evidence is found to support the 
associations between obesity and other diseases. In general, the odd ratios, risk ratios or hazard 
ratios are often higher in OW and OB people than in the normal-weight ones. However, the 
molecular mechanism of how OW and OB induce the development of other diseases has not been 
fully understood. Figures also showed that obesity and its-related disorders exert enormous 
pressure on the economy which is projected to increase. This review highlights the fact that 
obesity can lead to numerous lethal health problems; therefore, it requires a lot of economic 
resources to fight against this epidemic. 
Running title: Physical health and economic consequences of overweight and obesity 
Keywords: Obesity; overweight; metabolic disorder; physical health consequences; economic 
burden 
1. Introduction 
Overweight and obesity are “abnormal or excessive fat accumulation that may impair 
health” and characterized by Body Mass Index (BMI) [1]. According to WHO, BMI <18.50 
kg/m2 is defined as underweight,  from 18.50 to <24.90 kg/m2 is considered as normal weight, ≥
25-29.9 kg/m2 is defined as overweight or pre-obesity, and ≥30 kg/m2 is classified as obesity [2]. 
To measure nutritional status in children, however, age is taken into consideration. Overweight or 
obese under-5-year-old children have their weight-for-height greater than the median of Child 
Growth Standards (Created by WHO) plus 2 or 3 standard deviations (SD). Meanwhile, children 
aged 5-19 years whose BMI exceeds the median of WHO Growth Reference plus 1 SD are 
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classified as overweight, as opposed to 2 SD in case of obese children [1]. For Asian populations, 
an overweight person has a BMI range of  23 to less than 27.5 kg/m2 and an obese one has a BMI 
of at least 27 kg/m2 [3]. 
OW and OB are considered as one of the top health problems worldwide with 
approximately 2.8 million dead cases per annum [4, 5] and causing nearly 35.8 million disability 
adjusted life years (DALYs) [5]. According to WHO’s updated data in 2017, obesity has 
experienced a 3-fold increase over the past four decades (1975-2016) [1]. In 2016, over 1.9 
billion adults worldwide at the age of at least 18 years suffered from overweight, of whom more 
than 650 million were diagnosed with obesity (39% vs 13% of the global population, 
respectively). In 2016, 41 million under-5-year-old children, and >340 million 5-19-year-old 
children and adolescents were overweight and obese. In 1975, obese 5-19 year-olds of both sexes 
constituted only <1%, which then rose to 6% in females and 8% in males in 2016 [6]. Regarding 
age, children have a lower prevalence of obesity but higher rate of increase in obesity than adults 
[7]. 
The fastest rate of increase in obesity is predicted to occur in developing countries [8]. 
Developing countries experienced a greater increase in OW and OB prevalence than developed 
ones over the past two decades [9]. It was not until the early 1980-1990s when socioeconomic 
and nutritional conditions has improved that obesity came into existence as a big public health 
issue in economically developing countries [10]. Although most childhood OW and OB are 
recorded in developing countries, the percentage of  overweight and obese children in these 
countries (6.1%) were just over half of that in developed ones (11.7%) [9]. Upper middle-income 
countries had an obesity prevalence of 24% more than triple the figure in lower middle-income 
countries (7%). While the figure for women from high income nations resembled that in men, 
obese women in other countries accounted for a dominant percentage. For example, women 
doubled the number of men with obesity in low to lower middle-income countries [5]. 
Furthermore, prevalence of OW and OB in children in poor countries increased at a rate 30% 
faster than in higher-income ones [11]. 
WHO’s report in 2008 stated that overweight prevalence varied across the WHO Regions, 
from a low of 14% in South-East Asia (SEAR) to a concerning high of 62% in the Region of the 
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Americas (AMR), whereas the figure for obesity ranged between 3% in SEAR and 26% in AMR 
[5]. In terms of obesity, women outnumbered men in all of the six WHO Regions [5, 12]. As 
predicted by the Organization for Economic Co-operation and Development (OECD), obesity 
prevalence was projected to increase in nations like England, Mexico, USA, Italy, Korea, France, 
Spain and Switzerland in 2030 (between 9% and 47% of the population) [13]. 
2. Physical health consequences of obesity  
Several health consequences are related to OW and OB such as CVD, hypertension (high blood 
pressure - HBP), ischemic, different types of cancer, T2DM, dyslipidaemia and reproductive 
conditions [14-19]. 
Cardiovascular diseases 
Cardiovascular diseases are found more common among overweight and obese people and the 
risk of coronary heart disease (CHD) in obese patients is higher than that in healthy ones [20]. 
Alan J. Flint et al. found that the CHD risk in obese men (BMI>30 kg/m2) was 1.81 times higher 
than in normal-weight men (18.5≤ BMI≤22.9 kg/m2), compared to 2.16 times in the female group. 
Men with a waist circumference (WC) larger than 102.0 cm had a 2.2-fold higher risk of obesity 
than those with a 84-cm WC, while women with a 88-cm WC were 2.75 times higher at obesity 
risk than those having a 84-cm WC [21]. However, P. Dingli et al. suggested that the ratio of 
waist/hip, not BMI, be a predictor of acute myocardial infarction, or also known as heart attack 
[22]. According to Canoy D et al., if a women’s BMI increased by 5 kg/m2, she was 1.23 times 
more likely to become a new CHD case. Besides, there is a correlation between CHD incidence 
and BMI, CHD mortality in women with BMI<20 kg/m2 and at least 35 kg/m2 was 1.27 times and 
2.84 times higher than those with BMI from 20 to 35 kg/m2. For incident cases, the relative ratios 
(RRs) were 0.89 and 1.85, respectively [23]. Anne B. Gregory et al. found that people with raised 
BMI had higher prevalence of cardiac risk factors that normal ones. However, no association 
between BMI and cardiac-specific mortality after confounding factors were adjusted [24]. 
Strokes 
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Research has identified associations between strokes and obesity. Song YM et al found that 
elevated BMI was strongly associated to ischemic stroke risk in Korean men (aged 40 to 64; 
n=234,863) with age-adjusted hazard (HR) increased by 10% for each kg/m2 increase in BMI 
[25]. Similarly, a significant increase in total and ischemic stroke was observed in American 
women (aged 45 years or above; n=39,876) compared to normal ones, women with obesity (BMI 
≥30 kg/m2) were  at a higher risk of total stroke (HR = 1.5) and ischemic stroke (HR = 1.72) 
[26]. According to Zhou W et al., the stroke risk in Chinese individuals  with upper-body fat 
distribution and those with high fat accumulation was double that among those with normal fat 
accumulation [27]. By analyzing 25 studies, Strazzullo P. et al. concluded that the risk of 
ischemic stroke among overweight people (RR=1.22) and  obese participants was higher than 
normal-weight ones (RR 1.64) [28]. Recently, in a large scale study based in Israel with the 
participation of 2.3 million adolescents, the research group found that the mortality risk from 
adulthood stroke in participants with BMI ≥20 kg/m2 was higher than that in peoples with lower 
BMI. People with BMI ≥22.5 kg/m2 had higher risk of adulthood stroke-caused death than those 
with BMI from 17.5 to 19.9 kg/m2. Specifically, the HRs of stroke for participants increased with 
higher BMI [29]. 
Hypertension 
According to an US study, obesity was a better predictor of hypertension than of other 
cardiovascular diseases, such as heart attack and stroke [30]. Obesity was considered as the 
leading contributor to hypertension [31]. Kang, Y.S. explained that obesity contributes to 
hypertension as a result of the interaction between the adipose tissue’s secretion of adipokines and 
the inflammation of microvascular and perivascular adipose tissue [32]. Individuals with higher 
BMI have higher cardiac outputs, increase glomerular filtration rates [33], and their kidneys 
retains more sodium, leading to hypertension [34]. Several other mechanisms explain how obesity 
acts as a contributor of hypertension, such as insulin resistance, inflammation, and that 
neuropeptides (e.g. leptin), which possibly link obesity to the development of hypertension [35]. 
Research has shown that obesity increases a person’s risk of hypertension. People with 
OW and OB were more likely to suffer from hypertension than ones with normal-weight [30, 36-
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39]. Obese women are more prone to hypertension than obese men. The ratios were higher in 
women with higher BMI, while this association was not observed in men [40]. Both abdominal 
and central obesity contributed to hypertension in children [41]. A study in China and another in 
Poland concluded that hypertension among obese children was more common than non-obese 
ones [41, 42]. Besides, both types of blood pressure (systolic and diastolic) had positive 
associations with BMI [41, 42] 
Weight gain contributes to increased blood pressure, both systolic and diastolic, thereby 
accelerating the risk of CHD and stroke [38, 43]. On the contrary, when overweight patients lost 
weight following low-calorie diet and consuming less sodium, their systolic and diastolic blood 
pressure levels both decreased considerably, as concluded by Reisin E and Frohlich ED [38, 44]. 
Weight loss can also be obtained by bariatric surgery - a weight loss-induced surgical procedure. 
According to Onyewu et al. hypertension was no longer found in 45% of patients who underwent 
bariatric surgery [45]. These weight loss interventions, therefore, are often used for hypertensive 
patients. 
Type 2 Diabetes Mellitus (T2DM) 
Obese people are more susceptible to T2DM than those with normal weight. The risk of T2DM in 
obese patients varied across studies [36, 46]. Central obesity, but not general obesity, was a 
predictor of T2DM [47]. Waist-to-hip ratio played a better role than WC and BMI in predicting 
T2DM, and both general and abdominal obesity were positively associated with pre-diabetes and 
T2DM[48]. Obese and abdominal obese people of all ages, including children and adolescents 
[49], middle-aged men [39], and elderly people [50], a seemed to suffer from diabetes than non-
obese counterparts. While adults with obesity either during childhood or adulthood were not at 
risk of diabetes, the occurrence of obesity either in childhood alone or in both childhood and 
adulthood increased a person’s risk of diabetes in his or her adulthood [49]. In terms of gender, 
males with general and abdominal obesity had higher likelihood of developing diabetes than 
females [50]. 
Some studies showed that obesity and gestational diabetes mellitus (GDM) have a two-
way interaction. With a high pre-pregnancy BMI and obesity, women were more prone to GDM 
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[51], because insulin resistance and pre-diabetes were more commonly found in overweight and 
obese ones [52]. Mothers with GDM are a prediction for high BMI and obesity risk in their male 
children. However, there saw no strong correlation between obesity in female children and 
maternal GDM [53]. 
Cancer 
As obesity is a contributor to millions cases of cancer worldwide with an annual incidence of 
about 85,000 obesity-related cancer patients in the USA alone, the relation between obesity and 
cancer has become a great concern worldwide [54]. Furthermore, one investigation has shown 
every increase of 5 kg/m2 in BMI resulting in an increase of 10% in cancer mortality [54]. 
Raised BMI caused biogenic substances, including growth and sex hormones as well as 
inflammation-induced cytokines [55], to be produced over-abundantly, subsequently makes cells 
divide uncontrollably, leading to the formation of various types of cancer [5, 55]. Although the 
exact mechanism of how obesity causes cancer has been incompletely elucidated, the risk of 
cancer was proved to be associated to raised BMI [56]. 
Breast cancer is one the most common metastatic tumors  and a death-leading cancer in 
women globally [57-59]. A study in India [60] and two Consortiums [61, 62] showed that BMI 
was a strong predictor of this cancer in women. In other words, individuals with OW and OBhad 
more potential to incur breast cancer than ones with normal-weight [60]. Increased BMI predicted 
the higher risk of ovarian cancer; high-grade invasive serous cancer was not attributed to obesity 
[61]. However, another study pointed out a strong association between the high-grade serous 
subtype of ovarian cancer with obesity, but it was not statistically significant [62]. The 
relationship between prostate cancer and obesity is also mentioned [63, 64], and  low-grade 
prostate cancer was at a higher risk in obese patients  [63]. A study in the Netherlands showed 
that both male and female patients were more at risk of all obesity-related cancers combined as 
BMI increased. Males with higher BMI were more prone to non-sex-specific cancers while 
female patients were more susceptible to sex-specific ones. Prostate cancer had no association 
with the increased BMI [64]. 
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Dyslipidaemia 
The association between dyslipidaemia and obesity has long been identified. In 1998, Martins J. 
et al. observed dyslipidaemia being common among mild to moderate obese woman [65]. In a 
study of 13,770 2-17 year –old-Chinese-children Li Y. et al. found that  the odds of prevalent 
dyslipidaemia was 1.76 times higher in overweight than average-weight ones. The OR of having 
this condition in stunted overweight children was even higher, at 2.59 times [66]. When 
compared to average-weight Jordanian people, overweight and obese ones were also reported to 
have greater odds of having components of dyslipidaemia such as increase in triglyceride and 
total cholesterol, but reduction in  high-density lipoprotein cholesterol) [67]. Similarly, some 
other studies also pointed out positive associations between evaluated BMI and dyslipidaemia 
prevalence in Vietnamese children [16], American Indian children and adolescents [68], middle-
aged Iranians [69], or Chinese adults [70] . However, there remains controversial about whether 
obesity is an independent contributor to dyslipidaemia. For instance, dyslipidaemia was observed 
in certain unhealthy normal-weight individuals, but not found among the metabolically healthy 
ones with obesity [71, 72]. Ipsen et al. proposed that dyslipidaemia may be the risk factor of 
metabolic diseases rather than obesity [72]. Therefore, further studies about body weight and 
dyslipidaemia prevalence are needed for better understanding the mechanism underlying 
development of these two phenotypes. 
Reproductive disorders 
Psycho-physiologically, overweight or obesity is said to alter sexual function in both sexes [73-
76]. BMI was found to have a significant correlation to sexual function in studies on Italian 
women [74, 77]  and Iranian women [78]. However, obesity, but not overweight, increased the 
risk of erectile dysfunction in Chinese men over 40 years old [73]. French overweight or obese 
men had erectile dysfunction odd ratios of 2.69 or 2.58 in comparison with normal weight men, 
respectively [75]. 
OW and OB not only alter sexual function but also disrupt reproductive function in human. 
In children, obesity may delay puberty in boys and advance puberty in girls, but exactly how 
obesity affects puberty development is still unknown [79]. Some plausible mechanism of these 
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phenotypes are: central activation of gonadotropin-releasing hormone and gonadotropin secretion, 
obesity-related insulin resistance and hyperandrogenemia in girls; and increased aromatization of 
androgens to estrogens in boys [79]. Obesity has shown associations to subfertility and infertility 
in both men and women [80, 81]. By studying the level of anti-mullerian hormone (AMH), which 
helps predict the ovary’s capacity of producing healthy eggs for fertilization, in 35-47-year-old 
women, Freeman E. et al. reported lower AMH concentrations in higher BMI women [82]. In 
other words, ovarian aging was faster in obese than normal weight women. Spontaneous 
pregnancy probability was lower in obese women in that every 1 kg/m2 increase reduced the 
pregnancy rate by 4% [83]. For men, OW and OB were associated with genital tract inflammation 
(which consequently leads to infertility) and poor semen quality, or induced oxidative stress in 
testis [84-86]. 
3. Economic burden of overweight and obesity 
The burden of this metabolic disorder is undeniably immense. Seidell JC categorized the burden 
into three groups, namely direct costs, societal or indirect costs, and personal costs. The first 
group covers medical costs for treating obesity and  its related diseases [87]. 
The direct cost has seen an upward trend and it varies by country. In 2008, each 
overweight or obese individual in the USA spent $266 and $1,723 on healthcare, respectively. 
The combined cost of OW and OB amounted to $113.9 billion, accounting for 5-10% of the total 
national healthcare expenditure [88]. In 2010, $2,646 was spent on a male person with obesity, 
compared to $4,879 on a female person with obesity [89]. Medical costs per year in the USA are 
projected to increase to $66 billion by 2030 [90].  
The economic burden of OW and OB in some other countries, including Hong Kong, 
China, Korea and Brazil, was lower than that in the USA. In 2011, Brazil’s obesity-related direct 
costs amounted to about US $0.27 billion [91]. The medical costs at public hospitals in Hong 
Kong increased from US$ 0.29  to 0.43 billion in the period of1998 to 2002, consuming nearly 10% 
of the national healthcare expenditure in the public sector [92]. 
The costs of OW and OB -related diseases vary by country. In Brazil, the total healthcare 
costs for all  OW and OB-associated diseases totaled US$ 2.1 billion [93]. In 2003, W. Zhao et al. 
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reported that in China the direct costs of OW and OB -related diseases, in ascending order, were 
US$ 0.97 billion (diabetes), 2.58 billion (CHD), 3.12 billion (hypertension) and 4.08 billion 
(strokes) [94]. A Korean study on people aged at least 20 years estimated the total OW and OB -
related direct costs at about US$1.08 billion, including US $0.27 billion for inpatient care and 
US$0.30 million for outpatient care. In male patients, the costs for inpatient care due to ischaemic 
heart disease accounted for the highest part of seven types of inpatient costs. HBP contributed 
most significantly to the costs of either outpatient care or pharmaceuticals, irrespective of sex. 
The OW and OB -related cost of pharmaceuticals was > US $1 billion [95]. A study in English 
stated that the cost of 10 obesity-associated tumors in 2012-2013 was high (£0.32 billion). If the 
mean BMI gained 5kg/m2, it would experience a rise to £0.41 billion, and noticeably, the cost of 
uterus cancer alone would witness would increase most significantly, by 62% [96]. 
Societal or indirect expense refers to the value of lost work. Obese people perform less 
productively at work due to their absence from work, physical limitations, low life expectancy 
(premature deaths), disability pensions and unemployment benefits [87]. The Korean study 
estimated the OW and OB -related indirect cost to be US$ 706 million; the figure in men was 
nearly three times higher than that in women. Regardless of sex, the indirect cost for diabetes 
mellitus was highest. Productivity loss due to low life expectancy and hospitalization was 
calculated to be nearly US$ 444 million and US$ 74 million, respectively. Besides, the costs of 
time, transportation and nursing care were U$ 70 million, U$ 103 million and U$ 16 million [95]. 
Finally, in terms of personal costs, obese people are often stigmatized and discriminated at 
work due to their weight, obesity and related conditions, making their income lower than non-
obese people. Due to poor health status, obese employees are charged with higher premiums and 
healthcare costs [87]. According to Thompson et al. healthcare cost for treating five obesity-
related disorders, namely high cholesterol, hypertension, diabetes, stroke,  and coronary artery 
disease,  in OW and OB  people was at least US$ 4,400 higher than that in normal-weight ones, 
irrespective of sex. Besides, the healthcare cost for men surpassed that for women in all categories 
of evaluated BMI [39]. AC
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Obesity has been on the increase worldwide and occurring in all ages and gender, 
especially in the young generations. It not only causes disease burdens but also contributes to 
direct, indirect and personal costs. 
4. Conclusion  
Many studies have proved the associations between obesity and life-threatening conditions, 
including CVD, cardio-metabolic disorders, T2DM, cancer and reproductive disorders (Fig. 1). 
The prevalence of some obesity-related diseases varies by gender and age of obesity onset. 
However, the exact molecular mechanisms of how obesity leads to the onset of other diseases are 
still unclear. In addition, OW and OB have also placed a massive burden on both economy and 
healthcare systems (Fig. 1). This review highlights the need for further study of the mechanisms 
of interaction between ill health conditions and excess body fat. Such knowledge is crucial to 
provide effective prevention of obesity and its-related diseases. 
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Figure 1. Physical health and economic consequences of overweight and obesity 
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